4th Quarter - Report

IONIS PHARMACEUTICALS, INC. for IONIS PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the implementation of the Inflation Reduction Act. H.R.5547/S.476 - Maintaining Investments in New Innovation Act. H.R.7384/S.4583 - Creating Hope Reauthorization Act of 2024. H.R.7085 - BIOSECURE Act. H.R. 5539 - ORPHAN Cures Act.

LobbyistCovered position, as disclosed
JORDAN CHAPMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 7384 (118th), S. 476 (118th), S. 4583 (118th), H.R. 5547 (118th), H.R. 5539 (118th), H.R. 7085 (118th)

Medicare/Medicaid MMM

Issues related to the implementation of the Inflation Reduction Act. H.R.5547/S.476 - Maintaining Investments in New Innovation Act. H.R.7384/S.4583 - Creating Hope Reauthorization Act of 2024. H.R.7085 - BIOSECURE Act. H.R. 5539 - ORPHAN Cures Act.

LobbyistCovered position, as disclosed
JORDAN CHAPMAN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 7085 (118th), S. 4583 (118th), H.R. 5547 (118th), H.R. 5539 (118th), H.R. 7384 (118th), S. 476 (118th)

Taxation/Internal Revenue Code TAX

Issues related to the implementation of the Tax Cuts and Jobs Act of 2017. H.R.1350 - Camerons Law.

LobbyistCovered position, as disclosed
JORDAN CHAPMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1350 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.